A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study
Marta Español-Rego, Carlos Fernández-Martos, Elena Elez, Carles Foguet, Leire Pedrosa, Nuria Rodríguez, Ana Ruiz-Casado, Estela Pineda, Joan Cid, Raquel Cabezón, Helena Oliveres, Miquel Lozano, Angels Ginés, Angeles García-Criado, Juan Ramon Ayuso, Mario Pagés, Miriam Cuatrecasas, Ferràn Torres, Timothy Thomson, Marta Cascante
*Corresponding author for this work
- Universitat de Barcelona (UB)
- Instituto Valenciano de Oncología (IVO)
- Universitat Autònoma de Barcelona (UAB)
- Center for Biomedical Research Network on Cancer (CIBERONC)
- Universidad Autónoma de Madrid (UAM)
- Center for Biomedical Research Network (CIBER)
- Biostatistics Unit, School of Medicine of UAB
- Molecular Biology Institute of Barcelona (IBMB-CSIC)
- Peruvian University Cayetano Heredia
Research output: Contribution to journal › Article › Research › peer-review
29
Link opens in a new tab
Citations
(Scopus)